title: The situation and management of Clostridium difficile infection in Spain: an opinion document.
authors.affiliation: Emilio Bouza, Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain.ebouza@microb.net.
authors.forename: Emilio
authors.initials: E
authors.lastname: Bouza
authors.forename: Mercedes
authors.initials: M
authors.lastname: Marín
authors.forename: Teresa
authors.initials: T
authors.lastname: Peláez
authors.forename: Luis
authors.initials: L
authors.lastname: Alcalá
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D016360:Clostridioides difficile; D003142:Communication; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D003362:Cost-Benefit Analysis; D003967:Diarrhea / Q000175:diagnosis / Q000209:etiology; D004761:Enterocolitis, Pseudomembranous / Q000191:economics / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D004768:Enterotoxins / Q000032:analysis; D004784:Environmental Monitoring; D005243:Feces / Q000382:microbiology; D006801:Humans; D007167:Immunotherapy; D012008:Recurrence; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D004768:Enterotoxins